Rodolfo Hrosz new Sanofi India MDApril 18, 2022
Sanofi India Ltd, the India unit of French-drugmaker Sanofi SA, said today that its Board of Directors has appointed Rodolfo Hrosz as the company’s new Managing Director with effect from 1st June 2022, subject to regulatory approvals.
Hrosz joined Sanofi as General Manager of its consumer healthcare business in Brazil in 2017 and has successfully led the organisation through several transformative stages, right from the business unit’s inception to it becoming a top growth contributor and a digital-acceleration reference point within the Group. He brings with him a wealth of rich experience from commercial, marketing, and general management roles across several multinational companies. Prior to joining Sanofi, he has worked with Pfizer, LVMH, Heineken and Procter & Gamble in the US and Brazil.
“Rodolfo’s wide experience and diverse skills make him eminently suitable for this role and we wish him all the very best for every success in his new assignment,” said Sanofi India Chairman Aditya Narayan in a late Monday statement.
Since large companies, especially in the drug sector, are increasingly appreciating the value brought through diversity and inclusion, Sanofi India is now gearing up to mobilise energies, increase agility, and face the new challenges of the industry, involving these values. With Rodolfo Hrosz at the helm, the company expects that his diverse global experiences, particularly in key emerging markets, are assets that will hugely benefit its development.